Professor of Medicine-Cardiology; Medical Faculty Associates; Director, Pulmonary Hypertension Program; George Washington University Medicine and Health Sciences Clinical trial design and new therapies for pulmonary ... "I'm super excited and honored to join the Board of Directors," said Dr. Gomberg-Maitland. See insurances she accepts. Mardi Gomberg-Maitland, MD, Washington, DC | Cardiologist 2150 Pennsylvania Ave Nw Washington, DC 20037-3201 (202) 795-2792 (202) 741-2299 Map and Directions Doctor Profile Basics Medical Specialities CARDIOVASCULAR DISEASE (CARDIOLOGY) Credentials Doctor of Medicine (MD) AU - Gomberg-Maitland, Mardi. Mardi Irene Gomberg-Maitland, MD: LICENSE # 0101261135 Issue Date: 8/24/2016 Expiration Date: 2/29/2024 Status: Current Active In recent. Predicting Survival in Patients With Pulmonary Arterial ... PY - 2011/5. Patient Reviews for Dr. Mardi Gomberg-Maitland in ... The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. (202) 741-2323 Overview Ratings & Reviews Locations Experience Insurance OVERVIEW Dr. Mardi Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. Y1 - 2013/5/27. Internal Medicine , Pulmonologist and Cardiovascular Disease (202) 741-2323. The REVEAL registry risk score calculator in patients ... Dr. Mardi Gomberg-Maitland, MD: Washington, DC Dr. Gomberg-Maitland's office is located at 3300 Gallows Rd, Falls Church, VA 22042. Manreet K Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, Christine Pausch, David Pittow, Geoff Strange, James J Anderson, Carol Zhao, Jacqueline V Scott, Marek J Druzdzel, Jidapa Kraisangka, Lisa Lohmueller, James Antaki, Raymond L Benza European Respiratory Journal 2020; DOI: 10.1183/13993003.00008-2020 Abstract Background Current risk stratification tools in pulmonary arterial hypertension . Mardi Gomberg-Maitland, MD, MSc, FCCP, FACC, FAHA George Washington University Health and Medical Sciences Biography Dr. Gomberg-Maitland is the Director of the Pulmonary Hypertension Program, cardiologist and Professor of Medicine at the George Washington University Heart and Vascular Institute, Washington, DC. University of Chicago agrees to pay $2 ... - Chicago Sun-Times Mardi Gomberg-Maitland, MD is a Cardiologist. Pulmonary Hypertension), Primary Pulmonary Hypertension, and Pulmonary Hypertension. MARDI GOMBERG-MAITLAND MD | NPI:1548323066 | National ... Mardi Gomberg-Maitland, MD, MSc George Washington University Washington, DC. N2 - Importance: Pulmonary hypertension (PH) is a fatal disease. Louis W. Sullivan, M.D. Phase I Safety Study of Ranolazine in Pulmonary Arterial ... Dr. Mardi Gomberg-Maitland MD - Trusted Reviews | CareDash Pulmonary Circulation 2021 11: 1. PY - 2010/2. &get_box_var;ORIGINAL ARTICLE Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension Raymond L. Benza1, Mardi Gomberg-Maitland2, Teresa Demarco3, Adaani E. Frost4, Adam Torbicki5, David Langleben6, Tomas Pulido7, Priscilla Correa-Jaque1, Michael J. Passineau1, Howard W. Wiener8, Mayumi Tamari9, Tomomitsu Hirota9, Michiaki Kubo9, and Hemant K. Tiwari10 Find 4 listings related to Maitland Mardi G Md in Cicero on YP.com. Richard Johnson, MD University of Colorado Aurora, CO. Laura Mariani, MD, MS University of Michigan Ann Arbor, MI. Click to Call Dr. Mardi Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. Professor of Medicine . Find contact's direct phone number, email address, work history, and more. Mark Sarnak, MD, MS Tufts University To fulfill our mission, we provide research staff and investigators with the tools and resources they need to conduct impactful research and advance their careers, including: Study design support Collaboration facilitation Grantwriting and . Working with colleague Jalil Ahari, MD, assistant professor of medicine at the GW School of Medicine and . Mardi Gomberg-Maitland, MD, MSc, Inova Heart and Vascular Institute, Falls Church, VA, USA David Jenkins, FRCS, Papworth Hospital, Cambridge, United Kingdom 7:00 PM ADJOURN [ 101 ] CTEPH Master Class In Chronic Thromboembolic pulmonary Hypertension A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension. She attended and graduated from Albert Einstein College Of Medicine Of Yeshiva University in 1996, having over 26 years of diverse experience, especially in Cardiovascular Disease (Cardiology). Launch Date: December 15, 2021. Mardi Gomberg-Maitland Since the 1973 World Symposium on Pulmonary Hypertension, advancements in the understanding of pathophysiology and pathobiology have led to a myriad of pharmacotherapies for. Gomberg-Maitland M, Maitland ML, Barst RJ, et al. Mardi Gomberg-Maitland Director of the Pulmonary Hypertension Program at George Washington University, Professor of Medicine Direcor of Medical Research at The George Washington University School. Email Mardi Gomberg-Maitland, MD, MSc. Mardi Gomberg-Maitland, MD; David A. Baran, MD; Valentin Fuster, MD, PhD D uring the past 10 years, the philosophy of heart failure treatment has evolved from I just think it is going to be tricky, because when it comes to inotropes, I remember admitting patients to the hospital for a dobutamine holiday, as we used to call it. Biosketch. Address correspondence to Dr. Mardi Gomberg-Maitland, Director of Pulmonary Hypertension Center, University of Chicago Medical Center, 5841 South Maryland Avenue, MC5403, L08, Chicago, IL 60637, USA. Dr. McLaughlin: Our next speaker is Mardi Gomberg-Maitland who is an Associate Professor at the University of Chicago, and she is going to highlight the important role of the cardiologist in the diagnosis of PAH. She received her undergraduate degree from Yale University, her medical degree from Albert Einstein College of Medicine of Yeshiva University, and her MSc in Clinical Epidemiology from Harvard T.H. Pulmonary hypertension is a life-threatening disease that results in very high blood pressure limited to the arteries in the lungs resulting in heart failure. "PH treatments are typically directed toward the underlying cause, but there can be overlap between various patient groups," says Mardi Gomberg-Maitland, MD, MSc. Neither the hospital nor the cardiologist, Dr. Mardi Gomberg-Maitland, would comment. She plowed through all of my issues and set up a plan to help me recover. Learn more about her background, insurance she accepts, conditions she treats, and procedures on CareDash. She also serves as the medical director of The GW Medical Faculty Associates. Mission The mission of CTSI-CN is to advance clinical and translational research at Children's National Hospital and George Washington University. Y1 - 2011/5. Mardi Gomberg -Maitland, MD, FACC. View Mardi Gomberg-Maitland's business profile as Professor of Medicine at George Washington University. AU - Rich, Stuart. At the end of the 12 wk, patients were given the option to continue intravenous treprostinil. Detailed profile of Mardi Gomberg-maitland, MD, a Cardiologist (Heart Specialist) - General Willowbrook IL. Mardi Gomberg-Maitland . Dr. Mardi Gomberg-Maitland The GW Medical Faculty Associates welcomes Dr. Mardi Gomberg, as Professor of Medicine (Cardiology) and Director of the GW Advanced Pulmonary Hypertension Program. E-mail: mgomberg@bsd.uchicago.edu Search for more papers by this author In recent years, she has participated in dozens of multi-center, multinational research trials to explore new therapies for pulmonary hypertension. To help Washington, D.C., area residents who are fighting this disease, the George Washington University (GW) recruited Mardi Gomberg-Maitland, MD, to be the director of the newly established comprehensive pulmonary hypertension program. DOI: 10.1007/978--387-87429-6_81 Corpus ID: 68097978; Left Ventricular Diastolic Heart Function and Pulmonary Hypertension @inproceedings{Rich2011LeftVD, title={Left Ventricular Diastolic Heart Function and Pulmonary Hypertension}, author={Stuart Rich and Mardi Gomberg-Maitland}, year={2011} } In the past 18 months, the U.S. Food and Drug Administration approved macitentan, riociguat, and treprostinil as oral agents for the treatment of pulmonary arterial hypertension (PAH); riociguat also became the first agent approved for the treatment Jeremy P. Feldman, Mardi Gomberg-Maitland, Shelley M. Shapiro, Amy A. Lautenbach, Marty Morris, Jeff A. Murphy, Aaron B. Waxman, and Robert C. Bourge. Background The DelIVery for Pulmonary Arterial Hypertension clinical trial was a multi-center, prospective, single arm, Investigational Device Exemption study utilizing a fully implantable, program. AU - Vallakati, Ajay. Dr Mardi Gomberg‑Maitland is here to speak with us about that today. She has participated in dozens of multicenter, multinational research trials to explore new therapies for pulmonary hypertension. Clin Pharmacol Therap 2010; 87: 303 - 310. Pittsburgh, PA; George Washington University (Dr Gomberg- Maitland), Washington, DC; Intermountain Medical Center and the University of Utah (Dr Elliott), Salt Lake City, UT; Tufts Medical Read more to learn about Mardi Gomberg-Maitland, MD's background, education, and other specialties. Self-verified patient of Mardi I Gomberg-Maitland - Posted on July 5th, 2016. AU - Collander, Brett. - Mardi Gomberg-Maitland MD, MSc Professor of Medicine "The research community at GW has some of the best physician researchers and scientists and research coordinators in the field. Get information about Dr. Mardi Gomberg-Maitland MD, an internist in Washington, DC. Mardi Gomberg-Maitland, MD, MSc A revered senior colleague once said to me on my birthday, "Aging beats the alternative." As the propor-tion of older adults among the world's populations continues to increase, health assessment in "middle age" becomes increasingly important. Dr. Mardi Gomberg-Maitland Director, Pulmonary Hypertension Program. Gomberg-Maitland recently took a job as director of the comprehensive pulmonary hypertension program at George . National Provider Identifier: 1548323066. GOMBERG-MAITLAND: The last name of the provider. Statistical Analysis Study population and dosing data are presented as means SD; out-come data (including baseline data presented in the context of study Mardi Gomberg-Maitland, MD; David A. Baran, MD; Valentin Fuster, MD, PhD Author Affiliations Article Information From the Department of Cardiology, The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY. Stephan Rosenkranz. She graduated from Albert Einstein College of Medicine of Yeshiva University medical school in 1996. She has served as a consultant for Biomarin, Gilead, Medtronic, and Pfizer. Olivier Sitbon 1 , Mardi Gomberg-Maitland 2 , John Granton 3 , Michael I Lewis 4 , Stephen C Mathai 5 , Maurizio Rainisio 6 , Norman L Stockbridge 7 , Martin R Wilkins 8 , Roham T Zamanian 9 , Lewis J Rubin 10 Garcia, E. Kenneth Weir Interpreting P Values in Pharmacogenetic Studies: A Call for Process and Perspective She is available for patient consultation and treatment including access to both new and investigational treatments. Search Google Scholar for this author, Robert C. Bourge 2. By Michael L Maitland, David Heyer, and Mardi Gomberg-Maitland, Published on 07/02/20 Present guidelines from the American Background Current risk stratification tools in pulmonary arterial hypertension (PAH) are limited in their discriminatory abilities, partly due to the assumption that prognostic clinical variables have an independent and linear relationship to clinical outcomes. Pulmonary Hypertension: GW cardiology has established a Pulmonary Hypertension Center of Excellence directed by Dr. Mardi Gomberg-Maitland. Be sure to call ahead with Dr. Gomberg-Maitland to book an appointment. Y1 - 2010/2 Find other locations and directions. Mardi Gomberg-Maitland, M.D., M.Sc Mardi Gomberg-Maitland, M.D., M.Sc., is a cardiologist and professor of medicine at The GW University School of Medicine & Health Sciences. Mardi Gomberg-Maitland, M.D., MSc Professor of Medicine, Section of Cardiology, VCU School of Medicine Inova Heart and Vascular Institute Director of Complex Heart Failure (Right Ventricular Failure/HFpEF/Cardio-Oncology) Co-Director of the Clinical Trials Unit Hon. N2 - Background-Pulmonary vascular disease associated with left-side heart failure and preserved ejection fraction (PH-HFpEF) is an increasingly common cause of pulmonary hypertension. Dr. Mardi Gomberg-Maitland, MD, is a Cardiovascular Disease (Cardiology) specialist in Centreville, Virginia. Overview; Insurance; Office Info . Inova Heart and Vascular Institute. James C. Fang, Teresa Demarco, Michael M. Givertz, Barry A. Borlaug, Gregory D. Lewis, J. Eduardo Rame, Mardi Gomberg-Maitland, Srinivas Murali, Robert P. Frantz . Mr Miller is employed by ICON Late Phase & Outcomes Research, a company that receives research support from Actelion and other pharmaceutical companies. She has participated in over 45 clinical trials and has over 120 publications and 10 book chapters. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug . See reviews, photos, directions, phone numbers and more for Maitland Mardi G Md locations in Cicero, IL. Dr. Mardi Gomberg-Maitland, MD is a Cardiology Specialist in Falls Church, VA and has over 26 years of experience in the medical field. Mardi Gomberg-Maitland, MD, MSc & Marc Humbert, MD, PhD will focus on several important aspects of PAH management including a discussion of clinical trial data on emerging therapeutics for the management of PAH; and a review of strategies to optimize outcomes for patients with PAH. I have been her patient for over six years and I am doing very well. Dr. Gomberg-maitland works with six hundred and sixty-four doctors including Dr. Mitchell Posner and Dr. Iris Romero . Director of RV Failure, HFpEF , and Cardio -Oncology. Co-Director of the Clinical Trials Unit. She's a cardiologist and a professor of medicine at George Washington University in Washington, DC. CONSULTING FEES/HONORARIA: United Therapeutics(SIGNIFICANT), Acceleron(SIGNIFICANT), altavant(MODEST), Gilead Sciences, Inc. (MODEST) OTHER FINANCIAL BENEFIT: Janssen . Chan School of Public Health. She has participated in dozens of multicenter, multinational research trials to explore new therapies for pulmonary hypertension. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. She attended and graduated from Albert Einstein College Of Medicine Of Yeshiva University in 1996, having over 26 years of diverse experience, especially in Cardiovascular Disease (Cardiology). She has built a comprehensive management program including outpatient and inpatient diagnosis . Mardi Gomberg -Maitland, Director, Pulmonary Hypertension Program, George Washington University: ClinicalTrials.gov Identifier: NCT04882774 Other Study ID Numbers: RECAP001 : First Posted: May 12, 2021 Key Record Dates: Last Update Posted: May 12, 2021 Last Verified: May 2021 6 January, 2021 - Mardi Gomberg-Maitland, MD, MSc, Director of the Pulmonary Hypertension Program at the George Washington University Heart and Vascular Institute in Washington, DC USA, has been elected as a Director on the Board of the International Society for Heart and Lung Transplantation. Dr. Mardi Gomberg-Maitland, MD, is a Cardiovascular Disease (Cardiology) specialist in Annandale, Virginia. Dr Gomberg‑Maitland, you'll be speaking at the session "Clinical Controversies in Pulmonary Hypertension ‑‑ A Pro/Con Debate" at ATS 2021 annual meeting. AU - Gomberg-Maitland, Mardi. Assistant Professor of Medicine, Division of Cardiology Director, Pulmonary Hypertension Center Dr. Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. Qwant is a search engine that respects your privacy and ensures neutrality and impartiality. Dr. Gomberg-Maitland is an expert clinician and researcher in the field of pulmonary heart disease. Download Citation. : Prostacyclin Therapy 1587 and at Week 12. Dr Gomberg-Maitland has a patent filed entitled "Compositions and Methods for Treating Pulmonary Hypertension" for the use of sorafenib in pulmonary hypertension, WO/2007/087575. AU - Gomberg-Maitland, Mardi. Read ratings and reviews from other patients. I want to start by saying that this is the American Heart Association and that's why we're trying to define the important role of a . Robert C. Bourge . Dr. Gomberg-Maitland frequently treats Chronic Pulmonary Heart Diseases (incl. 2150 Pennsylvania Ave NW Fl 3, Washington, DC, 20037 (202) 741-2323 Overview Ratings & Reviews Locations Experience Insurance 26 Years Experience Languages Spoken English Doctor Finder.